APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lenalidomide Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lenalidomide Drug Market Analysis and Forecast 2026-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchLenalidomide Drug Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Lenalidomide Drug Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Lenalidomide Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lenalidomide Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Lenalidomide Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Lenalidomide Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lenalidomide Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lenalidomide Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lenalidomide Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lenalidomide Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Lenalidomide Drug include Bristol Myers Squibb. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lenalidomide Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lenalidomide Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Lenalidomide Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lenalidomide Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lenalidomide Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lenalidomide Drug sales, projected growth trends, production technology, application and end-user industry.

Lenalidomide Drug Segment by Company

Bristol Myers Squibb

Lenalidomide Drug Segment by Type

5 mg Capsules

25 mg Capsules

15 mg Capsules

10 mg Capsules

Lenalidomide Drug Segment by Application

Multiple myeloma (MM)

Myelodysplastic syndromes (MDS)

Other

Lenalidomide Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lenalidomide Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lenalidomide Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lenalidomide Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Lenalidomide Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Lenalidomide Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lenalidomide Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lenalidomide Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 5 mg Capsules Major Manufacturers Table 3. 25 mg Capsules Major Manufacturers Table 4. 15 mg Capsules Major Manufacturers Table 5. 10 mg Capsules Major Manufacturers Table 6. Global Lenalidomide Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Multiple myeloma (MM) Major Manufacturers Table 8. Myelodysplastic syndromes (MDS) Major Manufacturers Table 9. Other Major Manufacturers Table 10. Lenalidomide Drug Industry Trends Table 11. Lenalidomide Drug Industry Drivers Table 12. Lenalidomide Drug Industry Opportunities and Challenges Table 13. Lenalidomide Drug Industry Restraints Table 14. Global Lenalidomide Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Lenalidomide Drug Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Lenalidomide Drug Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Lenalidomide Drug Revenue Market Share by Region (2021-2026) Table 18. Global Lenalidomide Drug Revenue Market Share by Region (2027-2032) Table 19. Global Lenalidomide Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Lenalidomide Drug Sales by Region (2021-2026) & (k units) Table 21. Global Lenalidomide Drug Sales by Region (2027-2032) & (k units) Table 22. Global Lenalidomide Drug Sales Market Share by Region (2021-2026) Table 23. Global Lenalidomide Drug Sales Market Share by Region (2027-2032) Table 24. Global Lenalidomide Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Lenalidomide Drug Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Lenalidomide Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Lenalidomide Drug Sales Market Share by Manufacturers (2021-2026) Table 28. Global Lenalidomide Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global Lenalidomide Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Lenalidomide Drug Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Lenalidomide Drug Manufacturers, Product Type & Application Table 32. Global Lenalidomide Drug Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Lenalidomide Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Lenalidomide Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Lenalidomide Drug Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Lenalidomide Drug Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Lenalidomide Drug Revenue Market Share by Type (2021-2026) Table 39. Global Lenalidomide Drug Revenue Market Share by Type (2027-2032) Table 40. Global Lenalidomide Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Lenalidomide Drug Sales by Type (2021-2026) & (k units) Table 42. Global Lenalidomide Drug Sales by Type (2027-2032) & (k units) Table 43. Global Lenalidomide Drug Sales Market Share by Type (2021-2026) Table 44. Global Lenalidomide Drug Sales Market Share by Type (2027-2032) Table 45. Global Lenalidomide Drug Price by Type (2021-2026) & (US$/unit) Table 46. Global Lenalidomide Drug Price by Type (2027-2032) & (US$/unit) Table 47. Global Lenalidomide Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Lenalidomide Drug Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Lenalidomide Drug Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Lenalidomide Drug Revenue Market Share by Application (2021-2026) Table 51. Global Lenalidomide Drug Revenue Market Share by Application (2027-2032) Table 52. Global Lenalidomide Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Lenalidomide Drug Sales by Application (2021-2026) & (k units) Table 54. Global Lenalidomide Drug Sales by Application (2027-2032) & (k units) Table 55. Global Lenalidomide Drug Sales Market Share by Application (2021-2026) Table 56. Global Lenalidomide Drug Sales Market Share by Application (2027-2032) Table 57. Global Lenalidomide Drug Price by Application (2021-2026) & (US$/unit) Table 58. Global Lenalidomide Drug Price by Application (2027-2032) & (US$/unit) Table 59. Bristol Myers Squibb Company Information Table 60. Bristol Myers Squibb Business Overview Table 61. Bristol Myers Squibb Lenalidomide Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. Bristol Myers Squibb Lenalidomide Drug Product Portfolio Table 63. Bristol Myers Squibb Recent Development Table 64. North America Lenalidomide Drug Revenue by Type (2021-2026) & (US$ Million) Table 65. North America Lenalidomide Drug Revenue by Type (2027-2032) & (US$ Million) Table 66. North America Lenalidomide Drug Sales by Type (2021-2026) & (k units) Table 67. North America Lenalidomide Drug Sales by Type (2027-2032) & (k units) Table 68. North America Lenalidomide Drug Sales Price by Type (2021-2026) & (US$/unit) Table 69. North America Lenalidomide Drug Sales Price by Type (2027-2032) & (US$/unit) Table 70. North America Lenalidomide Drug Revenue by Application (2021-2026) & (US$ Million) Table 71. North America Lenalidomide Drug Revenue by Application (2027-2032) & (US$ Million) Table 72. North America Lenalidomide Drug Sales by Application (2021-2026) & (k units) Table 73. North America Lenalidomide Drug Sales by Application (2027-2032) & (k units) Table 74. North America Lenalidomide Drug Sales Price by Application (2021-2026) & (US$/unit) Table 75. North America Lenalidomide Drug Sales Price by Application (2027-2032) & (US$/unit) Table 76. North America Lenalidomide Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. North America Lenalidomide Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 78. North America Lenalidomide Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 79. North America Lenalidomide Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 80. North America Lenalidomide Drug Sales by Country (2021-2026) & (k units) Table 81. North America Lenalidomide Drug Sales by Country (2027-2032) & (k units) Table 82. North America Lenalidomide Drug Sales Price by Country (2021-2026) & (US$/unit) Table 83. North America Lenalidomide Drug Sales Price by Country (2027-2032) & (US$/unit) Table 84. United States Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 85. Canada Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 86. Mexico Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 87. Europe Lenalidomide Drug Revenue by Type (2021-2026) & (US$ Million) Table 88. Europe Lenalidomide Drug Revenue by Type (2027-2032) & (US$ Million) Table 89. Europe Lenalidomide Drug Sales by Type (2021-2026) & (k units) Table 90. Europe Lenalidomide Drug Sales by Type (2027-2032) & (k units) Table 91. Europe Lenalidomide Drug Sales Price by Type (2021-2026) & (US$/unit) Table 92. Europe Lenalidomide Drug Sales Price by Type (2027-2032) & (US$/unit) Table 93. Europe Lenalidomide Drug Revenue by Application (2021-2026) & (US$ Million) Table 94. Europe Lenalidomide Drug Revenue by Application (2027-2032) & (US$ Million) Table 95. Europe Lenalidomide Drug Sales by Application (2021-2026) & (k units) Table 96. Europe Lenalidomide Drug Sales by Application (2027-2032) & (k units) Table 97. Europe Lenalidomide Drug Sales Price by Application (2021-2026) & (US$/unit) Table 98. Europe Lenalidomide Drug Sales Price by Application (2027-2032) & (US$/unit) Table 99. Europe Lenalidomide Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Europe Lenalidomide Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. Europe Lenalidomide Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. Europe Lenalidomide Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 103. Europe Lenalidomide Drug Sales by Country (2021-2026) & (k units) Table 104. Europe Lenalidomide Drug Sales by Country (2027-2032) & (k units) Table 105. Europe Lenalidomide Drug Sales Price by Country (2021-2026) & (US$/unit) Table 106. Europe Lenalidomide Drug Sales Price by Country (2027-2032) & (US$/unit) Table 107. Germany Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 108. France Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 109. U.K. Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 110. Italy Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 111. Russia Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 112. Spain Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 113. Netherlands Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 114. Switzerland Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 115. Sweden Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 116. Poland Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 117. China Lenalidomide Drug Revenue by Type (2021-2026) & (US$ Million) Table 118. China Lenalidomide Drug Revenue by Type (2027-2032) & (US$ Million) Table 119. China Lenalidomide Drug Sales by Type (2021-2026) & (k units) Table 120. China Lenalidomide Drug Sales by Type (2027-2032) & (k units) Table 121. China Lenalidomide Drug Sales Price by Type (2021-2026) & (US$/unit) Table 122. China Lenalidomide Drug Sales Price by Type (2027-2032) & (US$/unit) Table 123. China Lenalidomide Drug Revenue by Application (2021-2026) & (US$ Million) Table 124. China Lenalidomide Drug Revenue by Application (2027-2032) & (US$ Million) Table 125. China Lenalidomide Drug Sales by Application (2021-2026) & (k units) Table 126. China Lenalidomide Drug Sales by Application (2027-2032) & (k units) Table 127. China Lenalidomide Drug Sales Price by Application (2021-2026) & (US$/unit) Table 128. China Lenalidomide Drug Sales Price by Application (2027-2032) & (US$/unit) Table 129. Asia Lenalidomide Drug Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Lenalidomide Drug Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Lenalidomide Drug Sales by Type (2021-2026) & (k units) Table 132. Asia Lenalidomide Drug Sales by Type (2027-2032) & (k units) Table 133. Asia Lenalidomide Drug Sales Price by Type (2021-2026) & (US$/unit) Table 134. Asia Lenalidomide Drug Sales Price by Type (2027-2032) & (US$/unit) Table 135. Asia Lenalidomide Drug Revenue by Application (2021-2026) & (US$ Million) Table 136. Asia Lenalidomide Drug Revenue by Application (2027-2032) & (US$ Million) Table 137. Asia Lenalidomide Drug Sales by Application (2021-2026) & (k units) Table 138. Asia Lenalidomide Drug Sales by Application (2027-2032) & (k units) Table 139. Asia Lenalidomide Drug Sales Price by Application (2021-2026) & (US$/unit) Table 140. Asia Lenalidomide Drug Sales Price by Application (2027-2032) & (US$/unit) Table 141. Asia Lenalidomide Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Asia Lenalidomide Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. Asia Lenalidomide Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. Asia Lenalidomide Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 145. Asia Lenalidomide Drug Sales by Country (2021-2026) & (k units) Table 146. Asia Lenalidomide Drug Sales by Country (2027-2032) & (k units) Table 147. Asia Lenalidomide Drug Sales Price by Country (2021-2026) & (US$/unit) Table 148. Asia Lenalidomide Drug Sales Price by Country (2027-2032) & (US$/unit) Table 149. Japan Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 150. South Korea Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 151. India Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 152. Australia Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 153. Taiwan Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 154. Southeast Asia Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 155. SAMEA Lenalidomide Drug Revenue by Type (2021-2026) & (US$ Million) Table 156. SAMEA Lenalidomide Drug Revenue by Type (2027-2032) & (US$ Million) Table 157. SAMEA Lenalidomide Drug Sales by Type (2021-2026) & (k units) Table 158. SAMEA Lenalidomide Drug Sales by Type (2027-2032) & (k units) Table 159. SAMEA Lenalidomide Drug Sales Price by Type (2021-2026) & (US$/unit) Table 160. SAMEA Lenalidomide Drug Sales Price by Type (2027-2032) & (US$/unit) Table 161. SAMEA Lenalidomide Drug Revenue by Application (2021-2026) & (US$ Million) Table 162. SAMEA Lenalidomide Drug Revenue by Application (2027-2032) & (US$ Million) Table 163. SAMEA Lenalidomide Drug Sales by Application (2021-2026) & (k units) Table 164. SAMEA Lenalidomide Drug Sales by Application (2027-2032) & (k units) Table 165. SAMEA Lenalidomide Drug Sales Price by Application (2021-2026) & (US$/unit) Table 166. SAMEA Lenalidomide Drug Sales Price by Application (2027-2032) & (US$/unit) Table 167. SAMEA Lenalidomide Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. SAMEA Lenalidomide Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. SAMEA Lenalidomide Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. SAMEA Lenalidomide Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 171. SAMEA Lenalidomide Drug Sales by Country (2021-2026) & (k units) Table 172. SAMEA Lenalidomide Drug Sales by Country (2027-2032) & (k units) Table 173. SAMEA Lenalidomide Drug Sales Price by Country (2021-2026) & (US$/unit) Table 174. SAMEA Lenalidomide Drug Sales Price by Country (2027-2032) & (US$/unit) Table 175. Brazil Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 176. Argentina Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 177. Chile Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 178. Colombia Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 179. Peru Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 180. Saudi Arabia Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 181. Israel Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 182. UAE Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 183. Turkey Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 184. Iran Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 185. Egypt Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Lenalidomide Drug Distributors List Table 189. Lenalidomide Drug Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Lenalidomide Drug Image Figure 2. Global Lenalidomide Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lenalidomide Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. 5 mg Capsules Image Figure 5. 25 mg Capsules Image Figure 6. 15 mg Capsules Image Figure 7. 10 mg Capsules Image Figure 8. Global Lenalidomide Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Lenalidomide Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. Multiple myeloma (MM) Image Figure 11. Myelodysplastic syndromes (MDS) Image Figure 12. Other Image Figure 13. Global Lenalidomide Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Lenalidomide Drug Revenue (2021-2032) & (US$ Million) Figure 15. Global Lenalidomide Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Lenalidomide Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Lenalidomide Drug Revenue Market Share by Region (2021-2032) Figure 18. Global Lenalidomide Drug Sales (2021-2032) & (k units) Figure 19. Global Lenalidomide Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Lenalidomide Drug Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Lenalidomide Drug Sales YoY (2021-2032) & (k units) Figure 22. Europe Lenalidomide Drug Sales YoY (2021-2032) & (k units) Figure 23. China Lenalidomide Drug Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Lenalidomide Drug Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Lenalidomide Drug Sales YoY (2021-2032) & (k units) Figure 26. Global Lenalidomide Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Lenalidomide Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Lenalidomide Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Lenalidomide Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Lenalidomide Drug Revenue Market Share by Type (2021-2032) Figure 32. Global Lenalidomide Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Lenalidomide Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Lenalidomide Drug Sales Market Share by Type (2021-2032) Figure 35. Global Lenalidomide Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Lenalidomide Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Lenalidomide Drug Revenue Market Share by Application (2021-2032) Figure 38. Global Lenalidomide Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Lenalidomide Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Lenalidomide Drug Sales Market Share by Application (2021-2032) Figure 41. North America Lenalidomide Drug Revenue Share by Type (2021-2032) Figure 42. North America Lenalidomide Drug Sales Share by Type (2021-2032) Figure 43. North America Lenalidomide Drug Revenue Share by Application (2021-2032) Figure 44. North America Lenalidomide Drug Sales Share by Application (2021-2032) Figure 45. North America Lenalidomide Drug Revenue Share by Country (2021-2032) Figure 46. North America Lenalidomide Drug Sales Share by Country (2021-2032) Figure 47. Europe Lenalidomide Drug Revenue Share by Type (2021-2032) Figure 48. Europe Lenalidomide Drug Sales Share by Type (2021-2032) Figure 49. Europe Lenalidomide Drug Revenue Share by Application (2021-2032) Figure 50. Europe Lenalidomide Drug Sales Share by Application (2021-2032) Figure 51. Europe Lenalidomide Drug Revenue Share by Country (2021-2032) Figure 52. Europe Lenalidomide Drug Sales Share by Country (2021-2032) Figure 53. China Lenalidomide Drug Revenue Share by Type (2021-2032) Figure 54. China Lenalidomide Drug Sales Share by Type (2021-2032) Figure 55. China Lenalidomide Drug Revenue Share by Application (2021-2032) Figure 56. China Lenalidomide Drug Sales Share by Application (2021-2032) Figure 57. Asia Lenalidomide Drug Revenue Share by Type (2021-2032) Figure 58. Asia Lenalidomide Drug Sales Share by Type (2021-2032) Figure 59. Asia Lenalidomide Drug Revenue Share by Application (2021-2032) Figure 60. Asia Lenalidomide Drug Sales Share by Application (2021-2032) Figure 61. Asia Lenalidomide Drug Revenue Share by Country (2021-2032) Figure 62. Asia Lenalidomide Drug Sales Share by Country (2021-2032) Figure 63. SAMEA Lenalidomide Drug Revenue Share by Type (2021-2032) Figure 64. SAMEA Lenalidomide Drug Sales Share by Type (2021-2032) Figure 65. SAMEA Lenalidomide Drug Revenue Share by Application (2021-2032) Figure 66. SAMEA Lenalidomide Drug Sales Share by Application (2021-2032) Figure 67. SAMEA Lenalidomide Drug Revenue Share by Country (2021-2032) Figure 68. SAMEA Lenalidomide Drug Sales Share by Country (2021-2032) Figure 69. Lenalidomide Drug Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Lenalidomide Drug Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg Capsules
  • 25 mg Capsules
  • 15 mg Capsules
  • 10 mg Capsules
Applications
  • Multiple myeloma (MM)
  • Myelodysplastic syndromes (MDS)
  • Other
Companies covered
  • Bristol Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lenalidomide Drug Market by Type
  3. 1.2.1 Global Lenalidomide Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 5 mg Capsules
  5. 1.2.3 25 mg Capsules
  6. 1.2.4 15 mg Capsules
  7. 1.2.5 10 mg Capsules
  8. 1.3 Lenalidomide Drug Market by Application
  9. 1.3.1 Global Lenalidomide Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Multiple myeloma (MM)
  11. 1.3.3 Myelodysplastic syndromes (MDS)
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Lenalidomide Drug Market Dynamics
  1. 2.1 Lenalidomide Drug Industry Trends
  2. 2.2 Lenalidomide Drug Industry Drivers
  3. 2.3 Lenalidomide Drug Industry Opportunities and Challenges
  4. 2.4 Lenalidomide Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Lenalidomide Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Lenalidomide Drug Revenue by Region
  3. 3.2.1 Global Lenalidomide Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lenalidomide Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Lenalidomide Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Lenalidomide Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Lenalidomide Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Lenalidomide Drug Sales by Region
  9. 3.4.1 Global Lenalidomide Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Lenalidomide Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Lenalidomide Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Lenalidomide Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Lenalidomide Drug Revenue by Manufacturers
  2. 4.1.1 Global Lenalidomide Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Lenalidomide Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Lenalidomide Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lenalidomide Drug Sales by Manufacturers
  6. 4.2.1 Global Lenalidomide Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Lenalidomide Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Lenalidomide Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Lenalidomide Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Lenalidomide Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Lenalidomide Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Lenalidomide Drug Manufacturers, Product Type & Application
  13. 4.7 Global Lenalidomide Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Lenalidomide Drug Market CR5 and HHI
  16. 4.8.2 2025 Lenalidomide Drug Tier 1, Tier 2, and Tier 3
5 Lenalidomide Drug Market by Type
  1. 5.1 Global Lenalidomide Drug Revenue by Type
  2. 5.1.1 Global Lenalidomide Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Lenalidomide Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Lenalidomide Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Lenalidomide Drug Sales by Type
  6. 5.2.1 Global Lenalidomide Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lenalidomide Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Lenalidomide Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Lenalidomide Drug Price by Type
6 Lenalidomide Drug Market by Application
  1. 6.1 Global Lenalidomide Drug Revenue by Application
  2. 6.1.1 Global Lenalidomide Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Lenalidomide Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Lenalidomide Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Lenalidomide Drug Sales by Application
  6. 6.2.1 Global Lenalidomide Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Lenalidomide Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Lenalidomide Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Lenalidomide Drug Price by Application
7 Company Profiles
  1. 7.1 Bristol Myers Squibb
  2. 7.1.1 Bristol Myers Squibb Company Information
  3. 7.1.2 Bristol Myers Squibb Business Overview
  4. 7.1.3 Bristol Myers Squibb Lenalidomide Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bristol Myers Squibb Lenalidomide Drug Product Portfolio
  6. 7.1.5 Bristol Myers Squibb Recent Developments
8 North America
  1. 8.1 North America Lenalidomide Drug Market Size by Type
  2. 8.1.1 North America Lenalidomide Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Lenalidomide Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Lenalidomide Drug Price by Type (2021-2032)
  5. 8.2 North America Lenalidomide Drug Market Size by Application
  6. 8.2.1 North America Lenalidomide Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Lenalidomide Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Lenalidomide Drug Price by Application (2021-2032)
  9. 8.3 North America Lenalidomide Drug Market Size by Country
  10. 8.3.1 North America Lenalidomide Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Lenalidomide Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Lenalidomide Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Lenalidomide Drug Market Size by Type
  2. 9.1.1 Europe Lenalidomide Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Lenalidomide Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Lenalidomide Drug Price by Type (2021-2032)
  5. 9.2 Europe Lenalidomide Drug Market Size by Application
  6. 9.2.1 Europe Lenalidomide Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Lenalidomide Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Lenalidomide Drug Price by Application (2021-2032)
  9. 9.3 Europe Lenalidomide Drug Market Size by Country
  10. 9.3.1 Europe Lenalidomide Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Lenalidomide Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Lenalidomide Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Lenalidomide Drug Market Size by Type
  2. 10.1.1 China Lenalidomide Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Lenalidomide Drug Sales by Type (2021-2032)
  4. 10.1.3 China Lenalidomide Drug Price by Type (2021-2032)
  5. 10.2 China Lenalidomide Drug Market Size by Application
  6. 10.2.1 China Lenalidomide Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Lenalidomide Drug Sales by Application (2021-2032)
  8. 10.2.3 China Lenalidomide Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lenalidomide Drug Market Size by Type
  2. 11.1.1 Asia Lenalidomide Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Lenalidomide Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Lenalidomide Drug Price by Type (2021-2032)
  5. 11.2 Asia Lenalidomide Drug Market Size by Application
  6. 11.2.1 Asia Lenalidomide Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Lenalidomide Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Lenalidomide Drug Price by Application (2021-2032)
  9. 11.3 Asia Lenalidomide Drug Market Size by Country
  10. 11.3.1 Asia Lenalidomide Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Lenalidomide Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Lenalidomide Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lenalidomide Drug Market Size by Type
  2. 12.1.1 SAMEA Lenalidomide Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Lenalidomide Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Lenalidomide Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Lenalidomide Drug Market Size by Application
  6. 12.2.1 SAMEA Lenalidomide Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Lenalidomide Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Lenalidomide Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Lenalidomide Drug Market Size by Country
  10. 12.3.1 SAMEA Lenalidomide Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Lenalidomide Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Lenalidomide Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Lenalidomide Drug Value Chain Analysis
  2. 13.1.1 Lenalidomide Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Lenalidomide Drug Production Mode & Process
  6. 13.2 Lenalidomide Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Lenalidomide Drug Distributors
  9. 13.2.3 Lenalidomide Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst